Nanomedicine for the Diagnosis and Therapy of COVID-19

The coronavirus disease-2019 (COVID-19) pandemics caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has been spreading around the world due to its high infection rate, long incubation period, as well as lack of effective diagnosis and therapy or vaccines, which is tearing gl...

Descripción completa

Guardado en:

Detalles Bibliográficos
Autores principales:	Yingruo Wang, Yuanping Hao, Shunxin Fa, Weiping Zheng, Changqing Yuan, Wanchun Wang
Formato:	article
Lenguaje:	EN
Publicado:	Frontiers Media S.A. 2021
Materias:	nanomaterials COVID-19 SARS-CoV-2 theranostic nanomedicine advanced materials Biotechnology TP248.13-248.65
Acceso en línea:	https://doaj.org/article/fdb9614af16940af9ae7dc4876b947fa
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

id	oai:doaj.org-article:fdb9614af16940af9ae7dc4876b947fa
record_format	dspace
spelling	oai:doaj.org-article:fdb9614af16940af9ae7dc4876b947fa2021-11-04T04:43:19ZNanomedicine for the Diagnosis and Therapy of COVID-192296-418510.3389/fbioe.2021.758121https://doaj.org/article/fdb9614af16940af9ae7dc4876b947fa2021-11-01T00:00:00Zhttps://www.frontiersin.org/articles/10.3389/fbioe.2021.758121/fullhttps://doaj.org/toc/2296-4185The coronavirus disease-2019 (COVID-19) pandemics caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has been spreading around the world due to its high infection rate, long incubation period, as well as lack of effective diagnosis and therapy or vaccines, which is tearing global health systems apart. It is an urgent demand for point-of-care diagnosis and effective treatment to prevent the spread of COVID-19. Currently, based on the rapid development of functional materials with unique physicochemical features through advanced fabrication and chemical modification, nanomaterials provide an emerging tool to detect SARS-CoV-2, inhibit the interplay in the virus and host cell interface, and enhance host immune response. In our manuscript, we summarized recent advances of nanomaterials for the diagnosis and therapy of COVID-19. The limitation, current challenges, and perspectives for the nano-diagnosis and nano-therapy of COVID-19 are proposed. The review is expected to enable researchers to understand the effect of nanomaterials for the diagnosis and therapy of COVID-19 and may catalyze breakthroughs in this area.Yingruo WangYuanping HaoShunxin FaShunxin FaWeiping ZhengWeiping ZhengChangqing YuanChangqing YuanWanchun WangFrontiers Media S.A.articlenanomaterialsCOVID-19SARS-CoV-2theranostic nanomedicineadvanced materialsBiotechnologyTP248.13-248.65ENFrontiers in Bioengineering and Biotechnology, Vol 9 (2021)
institution	DOAJ
collection	DOAJ
language	EN
topic	nanomaterials COVID-19 SARS-CoV-2 theranostic nanomedicine advanced materials Biotechnology TP248.13-248.65
spellingShingle	nanomaterials COVID-19 SARS-CoV-2 theranostic nanomedicine advanced materials Biotechnology TP248.13-248.65 Yingruo Wang Yuanping Hao Shunxin Fa Shunxin Fa Weiping Zheng Weiping Zheng Changqing Yuan Changqing Yuan Wanchun Wang Nanomedicine for the Diagnosis and Therapy of COVID-19
description	The coronavirus disease-2019 (COVID-19) pandemics caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has been spreading around the world due to its high infection rate, long incubation period, as well as lack of effective diagnosis and therapy or vaccines, which is tearing global health systems apart. It is an urgent demand for point-of-care diagnosis and effective treatment to prevent the spread of COVID-19. Currently, based on the rapid development of functional materials with unique physicochemical features through advanced fabrication and chemical modification, nanomaterials provide an emerging tool to detect SARS-CoV-2, inhibit the interplay in the virus and host cell interface, and enhance host immune response. In our manuscript, we summarized recent advances of nanomaterials for the diagnosis and therapy of COVID-19. The limitation, current challenges, and perspectives for the nano-diagnosis and nano-therapy of COVID-19 are proposed. The review is expected to enable researchers to understand the effect of nanomaterials for the diagnosis and therapy of COVID-19 and may catalyze breakthroughs in this area.
format	article
author	Yingruo Wang Yuanping Hao Shunxin Fa Shunxin Fa Weiping Zheng Weiping Zheng Changqing Yuan Changqing Yuan Wanchun Wang
author_facet	Yingruo Wang Yuanping Hao Shunxin Fa Shunxin Fa Weiping Zheng Weiping Zheng Changqing Yuan Changqing Yuan Wanchun Wang
author_sort	Yingruo Wang
title	Nanomedicine for the Diagnosis and Therapy of COVID-19
title_short	Nanomedicine for the Diagnosis and Therapy of COVID-19
title_full	Nanomedicine for the Diagnosis and Therapy of COVID-19
title_fullStr	Nanomedicine for the Diagnosis and Therapy of COVID-19
title_full_unstemmed	Nanomedicine for the Diagnosis and Therapy of COVID-19
title_sort	nanomedicine for the diagnosis and therapy of covid-19
publisher	Frontiers Media S.A.
publishDate	2021
url	https://doaj.org/article/fdb9614af16940af9ae7dc4876b947fa
work_keys_str_mv	AT yingruowang nanomedicineforthediagnosisandtherapyofcovid19 AT yuanpinghao nanomedicineforthediagnosisandtherapyofcovid19 AT shunxinfa nanomedicineforthediagnosisandtherapyofcovid19 AT shunxinfa nanomedicineforthediagnosisandtherapyofcovid19 AT weipingzheng nanomedicineforthediagnosisandtherapyofcovid19 AT weipingzheng nanomedicineforthediagnosisandtherapyofcovid19 AT changqingyuan nanomedicineforthediagnosisandtherapyofcovid19 AT changqingyuan nanomedicineforthediagnosisandtherapyofcovid19 AT wanchunwang nanomedicineforthediagnosisandtherapyofcovid19
_version_	1718445249960869888

Nanomedicine for the Diagnosis and Therapy of COVID-19

Ejemplares similares